NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

Search Results for Mycobacterium Bovis


Filter Articles: Clinical News | Consumer News | Business News | All News | More Options

Results 1 - 20      Next >


Refine Search
Display Mode: Context | Summary
Data from H.M. Vordermeier and colleagues advance knowledge in vaccines
2009 NOV 23 ... (TB) remains one of the most important infectious diseases of humans and animals. Mycobacterium bovis BCG, the only currently available TB vaccine, demonstrates variable levels of efficacy; ...
Subject: Vaccines
Price: $3.00
*
Data from I. Schiller and colleagues advance knowledge in tuberculosis
2009 NOV 2 ... reagents." "In this study, Rv0899 (outer membrane protein A of Mycobacterium tuberculosis [OmpATb]) was evaluated as a stimulation antigen in a gamma interferon ... OmpATb induced IFN-gamma responses in cattle experimentally infected with M. bovis as early and as persistently as ESAT-6 and CFP-10, the current lead diagnostic antigens. ...
Subject: Tuberculosis
Price: $3.00
*
Investigators at University of Pisa release new data on mycobacteria
2009 NOV 9 ... "The BCG1619c gene of Mycobacterium bovis bacillus Calmette-Guerin (BCG) encodes for a 24 kDa invasin-like protein and is ...
Subject: Mycobacteria
Price: $3.00
*
New data from V. Meikle et al illuminate research in mycobacteria
2009 NOV 2 ... "Culture filtrate and cell extracts from Mycobacterium bovis cultures contain molecules which could promote protective immunity to tuberculosis in ...
Subject: Mycobacteria
Price: $3.00
*
New findings from University of Padua in the area of tuberculosis published
2009 NOV 23 ... been characterized in mycobacteria. The chromosomes of Mycobacterium tuberculosis and Mycobacterium bovis encode five T7SSs (ESX-1 to ESX-5)," scientists writing in the Journal of Bacteriology ...
Subject: Tuberculosis
Price: $3.00
*
New mycobacteria data have been reported by R. Brucemicah and co-authors
2009 NOV 23 ... models for the important pathogens Mycobacterium tuberculosis, Mycobacterium leprae and Mycobacterium bovis. The kinetics of porphyrin synthesis after treatment with the precursors ALA and h-ALA ...
Subject: Mycobacteria
Price: $3.00
*
New research on mycobacteria from S. Gowtagesequeira and co-authors summarized
2009 NOV 23 ... recent research from Addlestone, the United Kingdom, "Deer are acknowledged as hosts of Mycobacterium bovis, the causative agent of bovine tuberculosis (bTB), and determining the prevalence of ...
Subject: Mycobacteria
Price: $3.00
*
Recent studies by A.M. Carmo and co-authors add new data to mycobacteria findings
2009 NOV 23 ... of BALB/c mice infected with Strongyloides venezuelensis and then co-infected with Mycobacterium bovis. The number of worms in the intestine, eggs in feces, cytokine production in lungs and ...
Subject: Mycobacteria
Price: $3.00
*
Reports from M.C. Gagliardi and colleagues advance knowledge in mycobacteria
2009 NOV 2 ... previously demonstrated that Mycobacterium tuberculosis and bacillus Calmette-Guerin (Mycobacterium bovis BCG) induce human monocytes to differentiate into CD1-dendritic cells (DC), which cannot ...
Subject: Mycobacteria
Price: $3.00
*
Reports outline tuberculosis cell biology study results from Kyung-Hee University, College of Oriental Medicine
2009 NOV 16 ... New investigation results, 'Global transcriptome analysis of the Mycobacterium bovis BCG response to sodium hypochlorite,' are detailed in a study published in Applied ...
Subject: Tuberculosis Cell Biology
Price: $3.00
*
Research from Medical University of Vienna, Institute of Physiology yields new findings on tuberculosis cell biology
2009 OCT 12 ... in yeast mitochondrial fatty acid synthase type 2,' are discussed in a new report. "Mycobacterium tuberculosis represents a severe threat to human health worldwide. Therefore, it is ... four candidates, FabG4/Rv0242c was recently shown to be essential for the survival of M. bovis BCG. The present work was initiated by assessing the suitability of yeast oar1Delta ...
Subject: Tuberculosis Cell Biology
Price: $3.00
*
Research from University of British Columbia yields new findings on tuberculosis
2009 NOV 16 ... little is known about the physiological or drug resistance roles of efflux pumps. Using Mycobacterium bovis BCG as a model system, we showed that deletion of the Rv1410c gene encoding the P55 ...
Subject: Tuberculosis
Price: $3.00
*
Research results from Y. Maeda and co-authors update knowledge of mycobacteria
2009 NOV 23 ... According to recent research from Tokyo, Japan, "The ability of a recombinant Mycobacterium bovis BCG strain that secretes major membrane protein II (MMP-II) of Mycobacterium leprae ...
Subject: Mycobacteria
Price: $3.00
*
Scientists at Prince of Songkla University, Department of Pharmaceutical Technology discuss research in liposomes
2009 NOV 16 ... liposomes containing rifampicin on respiratory cell lines and in vitro efficacy against Mycobacterium bovis in alveolar macrophages.' According to a study from Songkhla, Thailand, ...
Subject: Liposomes
Price: $3.00
*
Studies by F.A. Mir and co-authors describe new findings in tuberculosis
2009 NOV 23 ... According to a study from Berlin, Germany, "Concerns about the safety and efficacy of Mycobacterium bovis bacillus Calmette-Guerin (BCG) emphasize the need for alternative tuberculosis (TB) ...
Subject: Tuberculosis
Price: $3.00
*
Studies from A. Hayashi and co-researchers in the area of ovarian cancer published
2009 NOV 9 ... been widely debated, particularly in the gynecological field. The cell wall skeleton of Mycobacterium bovis Bacillus Calmette-Guerin (BCG-CWS) has been used as an effective adjuvant for ...
Subject: Ovarian Cancer
Price: $3.00
*
Studies from Iowa State University further understanding of tuberculosis
2009 OCT 19 ... this pathway exists only in M. tuberculosis and is not functional in the closely related Mycobacterium bovis because of an inactivating frameshift in the HPS-encoding gene," wrote F.M. Mann and ...
Subject: Tuberculosis
Price: $3.00
*
Study findings on Bacillus calmette-guerin vaccines are outlined in reports from Kuwait University, Medical Department
2009 NOV 2 ... cells (PBMC) obtained from diabetic TB patients, non-diabetic TB patients and Mycobacterium bovis bacilli Calmette-Guerin (BCG)-vaccinated healthy subjects were cultured in the presence ...
Subject: Bacillus Calmette-Guerin Vaccines
Price: $3.00
*
Study findings on life sciences are outlined in reports from L.R. Green and colleagues
2009 NOV 2 ... to a study from the United States, "Antibody responses are useful indicators of Mycobacterium bovis infection of cattle. Tests for such responses often use multiple M. bovis antigens as ...
Subject: Life Sciences
Price: $3.00
*
University of Texas details research in life sciences
2009 OCT 12 ... properties, is a unique adjuvant component able to enhance efficacy of the existing Mycobacterium bovis Bacillus Calmette Guerin (BCG) vaccine to protect against murine model of tuberculosis. ...
Subject: Life Sciences
Price: $3.00
*

Results 1 - 20      Next >




-----------------------
PR Login